• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人临床疑似急性心肌炎的 10 年生存结果:COVID-19 前时代的全国性研究。

10-year survival outcome after clinically suspected acute myocarditis in adults: A nationwide study in the pre-COVID-19 era.

机构信息

Division of Cardiology, Department of Internal Medicine, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, Republic of Korea.

Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

PLoS One. 2023 Jan 31;18(1):e0281296. doi: 10.1371/journal.pone.0281296. eCollection 2023.

DOI:10.1371/journal.pone.0281296
PMID:36719902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9888677/
Abstract

BACKGROUND

Clinical courses of acute myocarditis are heterogeneous in populations and geographic regions. There is a dearth of long-term outcomes data for acute myocarditis prior to the coronavirus disease pandemic, particularly in the older and female population. This study aimed to provide the nationwide epidemiologic approximates of clinically suspected acute myocarditis across adults of all ages over the long term.

METHODS

From the nationwide governmental health insurance database, a retrospective cohort comprised all patients aged 20-79 who were hospitalized for clinically suspected acute myocarditis without underlying cardiac diseases from 2006 to 2018. The complicated phenotype was defined as requiring hemodynamic or major organ support. Over 10 years, all-cause mortality and index event-driven excess mortality were evaluated according to young-adult (20-39 years), mid-life (40-59 years), and older-adult (60-79 years) age groups.

RESULTS

Among 2,988 patients (51.0±16.9 years, 46.2% women), 362 (12.1%) were of complicated phenotype. Of these, 163 (45.0%) had died within 1 month. All-cause death at 30 days occurred in 40 (4.7%), 52 (4.8%), and 105 (10.0%) patients in the young-adult, mid-life, and older-adult groups, respectively. For 10 years of follow-up, all-cause death occurred in 762 (25.5%). Even in young adult patients with non-complicated phenotypes, excess mortality remained higher compared to the general population.

CONCLUSION

In hospitalized patients with clinically suspected acute myocarditis, short-term mortality is high both in young and older adults, particularly those with comorbidities and severe clinical presentation. Furthermore, excess mortality remains high for at least 10 years after index hospitalization in young adults.

摘要

背景

急性心肌炎在不同人群和地理区域的临床病程存在异质性。在冠状病毒病大流行之前,急性心肌炎的长期结局数据匮乏,尤其是在老年和女性人群中。本研究旨在提供长期范围内所有年龄段成年人中临床疑似急性心肌炎的全国性流行病学估计。

方法

从全国性政府医疗保险数据库中,回顾性纳入了 2006 年至 2018 年期间因无基础心脏疾病住院的所有 20-79 岁临床疑似急性心肌炎患者。复杂表型定义为需要血流动力学或主要器官支持。在 10 年期间,根据青年(20-39 岁)、中年(40-59 岁)和老年(60-79 岁)年龄组评估全因死亡率和指数事件驱动的超额死亡率。

结果

在 2988 例患者中(51.0±16.9 岁,46.2%为女性),362 例(12.1%)为复杂表型。其中,163 例(45.0%)在 1 个月内死亡。30 天全因死亡率分别为青年组 40 例(4.7%)、中年组 52 例(4.8%)和老年组 105 例(10.0%)。10 年随访期间,全因死亡 762 例(25.5%)。即使在非复杂表型的青年患者中,与普通人群相比,超额死亡率仍较高。

结论

在临床疑似急性心肌炎的住院患者中,青年和老年患者的短期死亡率均较高,尤其是合并症和严重临床表现的患者。此外,指数住院后至少 10 年内,青年患者的超额死亡率仍较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/f13a879ec3ed/pone.0281296.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/3a1a845aef16/pone.0281296.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/19e4c1e850e2/pone.0281296.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/c20524a671c6/pone.0281296.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/f13a879ec3ed/pone.0281296.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/3a1a845aef16/pone.0281296.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/19e4c1e850e2/pone.0281296.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/c20524a671c6/pone.0281296.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d8f/9888677/f13a879ec3ed/pone.0281296.g004.jpg

相似文献

1
10-year survival outcome after clinically suspected acute myocarditis in adults: A nationwide study in the pre-COVID-19 era.成人临床疑似急性心肌炎的 10 年生存结果:COVID-19 前时代的全国性研究。
PLoS One. 2023 Jan 31;18(1):e0281296. doi: 10.1371/journal.pone.0281296. eCollection 2023.
2
Heart Failure and Mortality of Adult Survivors from Acute Myocarditis Requiring Intensive Care Treatment - A Nationwide Cohort Study.急性心肌炎需重症监护治疗的成年幸存者的心力衰竭和死亡率:一项全国性队列研究。
Int J Med Sci. 2017 Sep 20;14(12):1241-1250. doi: 10.7150/ijms.20618. eCollection 2017.
3
National Trends, Gender, Management, and Outcomes of Patients Hospitalized for Myocarditis.国家趋势、性别、管理与心肌炎住院患者结局。
Am J Cardiol. 2019 Jul 1;124(1):131-136. doi: 10.1016/j.amjcard.2019.03.036. Epub 2019 Apr 9.
4
Long-term prognosis following hospitalization for acute myocarditis - a matched nationwide cohort study.急性心肌炎住院后的长期预后 - 一项配对的全国队列研究。
Scand Cardiovasc J. 2021 Oct;55(5):264-269. doi: 10.1080/14017431.2021.1900596. Epub 2021 Mar 23.
5
Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.青少年和青年中临床上疑似与新冠病毒疫苗接种存在时间关联的心肌炎:新冠病毒疫苗接种后疑似心肌炎
Circulation. 2022 Feb;145(5):345-356. doi: 10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6.
6
Suspected myocarditis in patients with COVID-19: A multicenter case series.新型冠状病毒肺炎患者疑似心肌炎:一项多中心病例系列研究。
Medicine (Baltimore). 2021 Feb 26;100(8):e24552. doi: 10.1097/MD.0000000000024552.
7
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.美国青少年和年轻成年人接种 mRNA COVID-19 疫苗后至少 90 天的心肌炎结局:一项随访监测研究。
Lancet Child Adolesc Health. 2022 Nov;6(11):788-798. doi: 10.1016/S2352-4642(22)00244-9. Epub 2022 Sep 22.
8
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry.急性心肌炎当代患者队列的临床表现和转归:多中心伦巴第注册研究。
Circulation. 2018 Sep 11;138(11):1088-1099. doi: 10.1161/CIRCULATIONAHA.118.035319.
9
Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients.718365 例 COVID-19 患者中心肌炎和心包炎的患病率及临床结局。
Eur J Clin Invest. 2021 Nov;51(11):e13679. doi: 10.1111/eci.13679. Epub 2021 Sep 18.
10
Rate of cardiovascular events up to 8 years after uncomplicated myocarditis: a nationwide cohort study.心肌炎后 8 年内心血管事件的发生率:一项全国性队列研究。
Eur Heart J Acute Cardiovasc Care. 2024 May 28;13(5):401-410. doi: 10.1093/ehjacc/zuae021.

引用本文的文献

1
Cause-Specific Mortality in Patients Hospitalized for Myocarditis from 2004 to 2021: A Retrospective Statewide Population-Linkage Study.2004年至2021年因心肌炎住院患者的特定病因死亡率:一项全州范围的回顾性人群关联研究
J Clin Med. 2025 Jun 10;14(12):4089. doi: 10.3390/jcm14124089.
2
Insights and Challenges in Acute Myocarditis Management From a Korean Multicenter Registry.韩国多中心注册研究对急性心肌炎管理的见解与挑战
Korean Circ J. 2025 May;55(5):423-425. doi: 10.4070/kcj.2025.0033. Epub 2025 Mar 31.
3
Immune checkpoint inhibitor-associated myocarditis: a historical and comprehensive review.

本文引用的文献

1
Acute myocarditis revealing autoimmune and inflammatory disorders: Clinical presentation and outcome.急性心肌炎伴自身免疫和炎症性疾病:临床表现和结局。
Int J Cardiol. 2022 Mar 15;351:84-88. doi: 10.1016/j.ijcard.2021.12.058. Epub 2021 Dec 31.
2
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.与 COVID-19 疫苗接种或 SARS-CoV-2 感染相关的心肌炎、心包炎和心律失常风险。
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
3
Long-term prognosis following hospitalization for acute myocarditis - a matched nationwide cohort study.
免疫检查点抑制剂相关心肌炎:一项历史性的全面综述
Am J Physiol Heart Circ Physiol. 2025 Apr 1;328(4):H734-H751. doi: 10.1152/ajpheart.00687.2024. Epub 2025 Feb 10.
4
Myocarditis after COVID-19 and influenza infections: insights from a large data set.新冠病毒感染和流感感染后的心肌炎:来自大型数据集的见解
Open Heart. 2024 Nov 14;11(2):e002973. doi: 10.1136/openhrt-2024-002973.
急性心肌炎住院后的长期预后 - 一项配对的全国队列研究。
Scand Cardiovasc J. 2021 Oct;55(5):264-269. doi: 10.1080/14017431.2021.1900596. Epub 2021 Mar 23.
4
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.急性心肌炎和慢性炎症性心肌病的管理:专家共识文件。
Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.
5
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.COVID-19 感染住院患者心肌损伤的患病率和影响。
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8.
6
Epidemiology Characteristics and Outcome of Patients With Clinically Diagnosed Acute Myocarditis.临床诊断为急性心肌炎患者的流行病学特征和结局。
Am J Med. 2020 Apr;133(4):492-499. doi: 10.1016/j.amjmed.2019.10.015. Epub 2019 Nov 9.
7
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction.暴发性与非暴发性急性心肌炎患者的左心室收缩功能障碍。
J Am Coll Cardiol. 2019 Jul 23;74(3):299-311. doi: 10.1016/j.jacc.2019.04.063.
8
Natural History of Myocardial Injury and Chamber Remodeling in Acute Myocarditis.急性心肌炎中心肌损伤和心室重构的自然史。
Circ Cardiovasc Imaging. 2019 Jul;12(7):e008614. doi: 10.1161/CIRCIMAGING.118.008614. Epub 2019 Jul 4.
9
Prevalence and Prognostic Impact of Septal Late Gadolinium Enhancement in Acute Myocarditis With or Without Preserved Left Ventricular Function.节段性延迟钆增强在左心室射血分数保留或不保留的急性心肌炎中的患病率和预后影响。
Am J Cardiol. 2018 Dec 1;122(11):1955-1958. doi: 10.1016/j.amjcard.2018.08.038. Epub 2018 Sep 13.
10
Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment.急性和暴发性心肌炎:诊断与治疗的实用临床方法。
Curr Cardiol Rep. 2018 Sep 26;20(11):114. doi: 10.1007/s11886-018-1054-z.